392 related articles for article (PubMed ID: 29077858)
1. Proteomics and phosphoproteomics in precision medicine: applications and challenges.
Giudice G; Petsalaki E
Brief Bioinform; 2019 May; 20(3):767-777. PubMed ID: 29077858
[TBL] [Abstract][Full Text] [Related]
2. The Case for Proteomics and Phospho-Proteomics in Personalized Cancer Medicine.
Doll S; Gnad F; Mann M
Proteomics Clin Appl; 2019 Mar; 13(2):e1800113. PubMed ID: 30790462
[TBL] [Abstract][Full Text] [Related]
3. Implementation of Clinical Phosphoproteomics and Proteomics for Personalized Medicine.
Casado P; Hijazi M; Gerdes H; Cutillas PR
Methods Mol Biol; 2022; 2420():87-106. PubMed ID: 34905168
[TBL] [Abstract][Full Text] [Related]
4. Personalization of prostate cancer therapy through phosphoproteomics.
Yang W; Freeman MR; Kyprianou N
Nat Rev Urol; 2018 Aug; 15(8):483-497. PubMed ID: 29752463
[TBL] [Abstract][Full Text] [Related]
5. Are innovation and new technologies in precision medicine paving a new era in patients centric care?
Seyhan AA; Carini C
J Transl Med; 2019 Apr; 17(1):114. PubMed ID: 30953518
[TBL] [Abstract][Full Text] [Related]
6. Integrative methods for analyzing big data in precision medicine.
Gligorijević V; Malod-Dognin N; Pržulj N
Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817
[TBL] [Abstract][Full Text] [Related]
7. Advancing translational research and precision medicine with targeted proteomics.
Uzozie AC; Aebersold R
J Proteomics; 2018 Oct; 189():1-10. PubMed ID: 29476807
[TBL] [Abstract][Full Text] [Related]
8. Power of proteomics and progress in precision medicine - 13th central and eastern European proteomic conference (CEEPC), Ustroń, Poland.
Gadher SJ; Widlak P; Kovarova H
Expert Rev Proteomics; 2020 May; 17(5):335-340. PubMed ID: 32510255
[TBL] [Abstract][Full Text] [Related]
9. Role of phosphoproteomics in the development of personalized cancer therapies.
Cutillas PR
Proteomics Clin Appl; 2015 Apr; 9(3-4):383-95. PubMed ID: 25488289
[TBL] [Abstract][Full Text] [Related]
10. Leveraging proteomics in orphan disease research: pitfalls and potential.
Braconi D; Bernardini G; Spiga O; Santucci A
Expert Rev Proteomics; 2021 Apr; 18(4):315-327. PubMed ID: 33861161
[No Abstract] [Full Text] [Related]
11. Phosphoproteomics-based network medicine.
Liu Z; Wang Y; Xue Y
FEBS J; 2013 Nov; 280(22):5696-704. PubMed ID: 23751130
[TBL] [Abstract][Full Text] [Related]
12. Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection.
Labots M; van der Mijn JC; Beekhof R; Piersma SR; de Goeij-de Haas RR; Pham TV; Knol JC; Dekker H; van Grieken NCT; Verheul HMW; Jiménez CR
J Proteomics; 2017 Jun; 162():99-107. PubMed ID: 28442448
[TBL] [Abstract][Full Text] [Related]
13. Sarcoidosis: proteomics and new perspectives for improving personalized medicine.
Landi C; Carleo A; Cillis G; Rottoli P
Expert Rev Proteomics; 2018 Oct; 15(10):829-835. PubMed ID: 30251559
[TBL] [Abstract][Full Text] [Related]
14. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
Tebani A; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of plasma proteomics and peptidomics: Towards precision medicine.
He B; Huang Z; Huang C; Nice EC
Proteomics Clin Appl; 2022 Nov; 16(6):e2100097. PubMed ID: 35490333
[TBL] [Abstract][Full Text] [Related]
16. Molecular subtyping of cancer and nomination of kinase candidates for inhibition with phosphoproteomics: Reanalysis of CPTAC ovarian cancer.
Tong M; Yu C; Zhan D; Zhang M; Zhen B; Zhu W; Wang Y; Wu C; He F; Qin J; Li T
EBioMedicine; 2019 Feb; 40():305-317. PubMed ID: 30594550
[TBL] [Abstract][Full Text] [Related]
17. Role of Proteomics in the Development of Personalized Medicine.
Jain KK
Adv Protein Chem Struct Biol; 2016; 102():41-52. PubMed ID: 26827601
[TBL] [Abstract][Full Text] [Related]
18. Computational analysis of phosphoproteomics: progresses and perspectives.
Ren J; Gao X; Liu Z; Cao J; Ma Q; Xue Y
Curr Protein Pept Sci; 2011 Nov; 12(7):591-601. PubMed ID: 21827424
[TBL] [Abstract][Full Text] [Related]
19. Proteomics appending a complementary dimension to precision oncotherapy.
Zhou Z; Zhang R; Zhou A; Lv J; Chen S; Zou H; Zhang G; Lin T; Wang Z; Zhang Y; Weng S; Han X; Liu Z
Comput Struct Biotechnol J; 2024 Dec; 23():1725-1739. PubMed ID: 38689716
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
